Browse EX-10 agreements

August 18, 2026

Mr. John Rogers

Dear John,

We are pleased to welcome you to Baxter International Inc. (“Baxter” or the “Company”) and to confirm our verbal offer of employment, subject to formal approval by the Board of Directors of Baxter (the “Board”). This is where your purpose accelerates our mission to Save and Sustain Lives. At Baxter, you will join approximately 38,000 colleagues, in 100 countries, who share common traits like being reliable, ethical, and caring. Together, we create a place where we are happy, successful and inspire each other.

…

INDEPENDENT DIRECTOR AGREEMENT

THIS INDEPENDENT DIRECTOR AGREEMENT (the “Agreement”), is entered into as of August 18, 2026 (the “Effective Date”), by and between Ocean Capital Acquisition Corporation, a British Virgin Islands business company (the “Company”), and Mr. Richard T. Betts, an individual (the “Director”) (individually, each a “Party” and collectively, the “Parties”).

WHEREAS, the Company desires to appoint the Director as its director of the Board to assure itself of the services of the Director during the term of Appointment (as defined below).

WHEREAS, the Director desires to be appointed by the Company as its director during the term of Appointment and upon the terms and conditions of this Agreement.

NOW THEREFORE, in consideration of the mutual promises contained herein, the adequacy and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the Parties hereby agree as follows:

1.	**POSITION **

…

INDEPENDENT DIRECTOR AGREEMENT

THIS INDEPENDENT DIRECTOR AGREEMENT (the “Agreement”), is entered into as of August 16, 2026 (the “Effective Date”), by and between Ocean Capital Acquisition Corporation, a British Virgin Islands business company (the “Company”), and Mr. Wei-Chieh Hao, an individual (the “Director”) (individually, each a “Party” and collectively, the “Parties”).

WHEREAS, the Company desires to appoint the Director as its director of the Board to assure itself of the services of the Director during the term of Appointment (as defined below).

WHEREAS, the Director desires to be appointed by the Company as its director during the term of Appointment and upon the terms and conditions of this Agreement.

NOW THEREFORE, in consideration of the mutual promises contained herein, the adequacy and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the Parties hereby agree as follows:

1.	**POSITION **

…

** **

Lock-Up Agreement

** **

August 19, 2026

Rank One Computing Corporation

1290 Broadway, Suite 1200

Denver, Colorado 80203

Ladies and Gentlemen:

Whereas the undersigned previously entered a lock-up agreement with The Benchmark Company, LLC in connection with the initial public offering of common stock, par value $0.01 per share (the “Common Stock”), of Rank One Computing Corporation, a corporation formed under the laws of the State of Colorado (collectively with its subsidiaries and affiliates the “Company”).

…

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS A TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

EXCLUSIVE LICENSE AGREEMENT

This Exclusive License Agreement (“Agreement”) is entered into this 20thday of August, 2026 (“Effective Date”), by and between Kiora Pharmaceuticals, Inc., a company organized under the laws of Delaware and having its principal place of business at 169 Saxony Road, Suite 212, Encinitas CA 92024 USA (“Kiora”) and Chong Kun Dang Pharmaceutical Corporation, a corporation organized under the laws of Republic of Korea and having its principal place of business at 8, Chungjeong-ro, Seodaemun-gu, Seoul, 03742, Republic of Korea (“CKD”). Kiora and CKD are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.

RECITALS

WHEREAS, Kiora owns or otherwise controls certain intellectual property related to the treatment of inherited retinal disease;

…

CHANGE IN CONTROL AGREEMENT

THIS CHANGE IN CONTROL AGREEMENT (this “Agreement”), dated as of this 18th day of August, 2026, is entered into by and among** MICHAEL R. MILLER **(“Executive”) and LCNB NATIONAL BANK (the “Company”) and LCNB CORP. (the “Parent”), and is effective as of August 18, 2026 (the “Effective Date”).

RECITALS:

WHEREAS, the Company is a wholly-owned subsidiary of the Parent; and

WHEREAS, the Company desires to assure continuity of management and fair treatment of its executives in the event of a possible Change in Control (as defined below) transaction; and

…

CHANGE IN CONTROL AGREEMENT

THIS CHANGE IN CONTROL AGREEMENT (this “Agreement”), dated as of this 18th day of August, 2026, is entered into by and among** ANDREW WALLACE **(“Executive”) and LCNB NATIONAL BANK (the “Company”) and LCNB CORP. (the “Parent”), and is effective as of August 18, 2026 (the “Effective Date”).

RECITALS:

WHEREAS, the Company is a wholly-owned subsidiary of the Parent; and

WHEREAS, the Company desires to assure continuity of management and fair treatment of its executives in the event of a possible Change in Control (as defined below) transaction; and

…

CHANGE IN CONTROL AGREEMENT

THIS CHANGE IN CONTROL AGREEMENT (this “Agreement”), dated as of this 18th day of August, 2026, is entered into by and among** BRADLEY A. RUPPERT **(“Executive”) and LCNB NATIONAL BANK (the “Company”) and LCNB CORP. (the “Parent”), and is effective as of August 18, 2026 (the “Effective Date”).

RECITALS:

WHEREAS, the Company is a wholly-owned subsidiary of the Parent; and

WHEREAS, the Company desires to assure continuity of management and fair treatment of its executives in the event of a possible Change in Control (as defined below) transaction; and

…

Exhibit 10.1

CHANGE IN CONTROL AGREEMENT

THIS CHANGE IN CONTROL AGREEMENT (this “Agreement”), dated as of this 18th day of August, 2026, is entered into by and among** ERIC J. MEILSTRUP **(“Executive”) and LCNB NATIONAL BANK (the “Company”) and LCNB CORP. (the “Parent”), and is effective as of August 18, 2026 (the “Effective Date”).

RECITALS:

WHEREAS, the Company is a wholly-owned subsidiary of the Parent; and

WHEREAS, the Company desires to assure continuity of management and fair treatment of its executives in the event of a possible Change in Control (as defined below) transaction; and

…

CHANGE IN CONTROL AGREEMENT

THIS CHANGE IN CONTROL AGREEMENT (this “Agreement”), dated as of this 18th day of August, 2026, is entered into by and among** ROBERT C. HAINES II **(“Executive”) and LCNB NATIONAL BANK (the “Company”) and LCNB CORP. (the “Parent”), and is effective as of August 18, 2026 (the “Effective Date”).

RECITALS:

WHEREAS, the Company is a wholly-owned subsidiary of the Parent; and

WHEREAS, the Company desires to assure continuity of management and fair treatment of its executives in the event of a possible Change in Control (as defined below) transaction; and

…

VOTING AGREEMENT

This Voting Agreement (this “Agreement”) is entered into as of August 18, 2026 (the “Effective Date”), by and among Streeterville Capital, LLC, a Utah limited liability company (“Investor”), and each of the undersigned shareholders of Company (as defined below) (each, a “Major Stockholder,” and collectively, the “Major Stockholders”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Purchase Agreement.

A.            Investor and Datavault AI Inc., a Delaware corporation (“Company”), are parties to that certain Securities Purchase Agreement of even date herewith (the “Purchase Agreement”), pursuant to which Company issued to Investor that certain Convertible Promissory Note in the original principal amount of $25,030,000.00 (the “Note”, and together with the Purchase Agreement and all other documents entered into in conjunction therewith, the “Transaction Documents”).

…

Securities Purchase Agreement

This Securities Purchase Agreement (this “Agreement”), dated as of August 18, 2026, is entered into by and between Datavault AI Inc., a Delaware corporation (“Company”), and Streeterville Capital, LLC, a Utah limited liability company (“Investor”).

A.            Investor desires to purchase and Company desires to issue and sell, upon the terms and conditions set forth in this Agreement: (i) a Convertible Promissory Note in the original principal amount of $25,030,000.00 in the form attached hereto as Exhibit A (the “Note”), convertible into Company’s shares of common stock, $0.0001 par value per share (the “Common Shares”), and (ii) 15,000,000 Common Shares to be used as pre-delivery shares (the “Pre-Delivery Shares”).

B.            This Agreement, the Note, and all other certificates, documents, agreements, resolutions and instruments delivered to any party under or in connection with this Agreement, as the same may be amended from time to time, are collectively referred to herein as the “Transaction Documents”.

…